Prostate implant reconstruction from C-arm images with motion-compensated tomosynthesis
- PMID: 21992346
- PMCID: PMC3189971
- DOI: 10.1118/1.3633897
Prostate implant reconstruction from C-arm images with motion-compensated tomosynthesis
Abstract
Purpose: Accurate localization of prostate implants from several C-arm images is necessary for ultrasound-fluoroscopy fusion and intraoperative dosimetry. The authors propose a computational motion compensation method for tomosynthesis-based reconstruction that enables 3D localization of prostate implants from C-arm images despite C-arm oscillation and sagging.
Methods: Five C-arm images are captured by rotating the C-arm around its primary axis, while measuring its rotation angle using a protractor or the C-arm joint encoder. The C-arm images are processed to obtain binary seed-only images from which a volume of interest is reconstructed. The motion compensation algorithm, iteratively, compensates for 2D translational motion of the C-arm by maximizing the number of voxels that project on a seed projection in all of the images. This obviates the need for C-arm full pose tracking traditionally implemented using radio-opaque fiducials or external trackers. The proposed reconstruction method is tested in simulations, in a phantom study and on ten patient data sets.
Results: In a phantom implanted with 136 dummy seeds, the seed detection rate was 100% with a localization error of 0.86 ± 0.44 mm (Mean ± STD) compared to CT. For patient data sets, a detection rate of 99.5% was achieved in approximately 1 min per patient. The reconstruction results for patient data sets were compared against an available matching-based reconstruction method and showed relative localization difference of 0.5 ± 0.4 mm.
Conclusions: The motion compensation method can successfully compensate for large C-arm motion without using radio-opaque fiducial or external trackers. Considering the efficacy of the algorithm, its successful reconstruction rate and low computational burden, the algorithm is feasible for clinical use.
Figures











References
-
- Morris W., Keyes M., Palma D., Spadinger I., McKenzie M., Agranovich A., Pickles T., Liu M., Kwan W., Wu J., Berthelet E., and Pai H., “Population-based study of biochemical and survival outcomes after permanent 125I brachytherapy for low- and intermediate-risk prostate cancer,” Urology 73, 860–865 (2009).10.1016/j.urology.2008.07.064 - DOI - PubMed
-
- Morris W. J., Keyes M., Palma D., McKenzie M., Spadinger I., Agranovich A., Pickles T., Liu M., Kwan W., Wu J., Lapointe V., Berthelet E., Pai H., Harrison R., Kwa W., Bucci J., Racz V., and Woods R., “Evaluation of dosimetric parameters and disease response after 125iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. 73, 1432–1438 (2009).10.1016/j.ijrobp.2008.07.042 - DOI - PubMed
-
- Prestidge B. R., Prete J. J., Buchholz T. A., Friedland J. L., Stock R. G., Grimm P. D., and Bice W. S., “A survey of current clinical practice of permanent prostate brachytherapy in the United States,” Int. J. Radiat. Oncol., Biol., Phys. 40, 461–465 (1998).10.1016/S0360-3016(97)00715-3 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials